75TiP A multicenter, open-label, phase II trial evaluating the safety and efficacy of folate receptor alpha (FRα) antibody-drug conjugate (ADC) farletuzumab ecteribulin (FZEC*) in patients with previously treated, metastatic non-small cell lung cancer (NSCLC) adenocarcinoma (AC)
| Autor: | Planchard, D., Paz-Ares, L., Spira, A., Felip, E., McCune, S., Cascella, T., Dennie, J., Bhagavatheeswaran, P., Dumitru, C., Borghaei, H. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology April 2023 18(4) Supplement:S83-S84 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|